Clinuvel (CUV) Shares Give Back Returns
Max Wagner
September 25, 2019
The Clinuvel Pharmaceuticals Limited (ASX:CUV) share price was trading 5%
Clinuvel Pharmaceuticals Limited (ASX:CUV) is a global biopharmaceuticals company with a focus on developing and delivering treatments for patients with a range of severe genetic and skin disorders. Clinuvel’s main product is called SCENESSE, which it develops and self-distributes.
The Clinuvel Pharmaceuticals Limited (ASX:CUV) share price was trading 5%
The Clinuvel Pharmaceuticals Limited (ASX:CUV) share price had lifted 4.8%
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is
Clinuvel Pharmaceuticals Limited (ASX:CUV) shares are up nearly 90% year-to-date
One of the changes in the S&P Dow Jones Indices
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
Here you go: A $50,000 per year passive income special report
Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.
Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.